324 related articles for article (PubMed ID: 2934477)
1. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.
Thiele DL; Lipsky PE
J Immunol; 1986 Feb; 136(3):1038-48. PubMed ID: 2934477
[TBL] [Abstract][Full Text] [Related]
2. Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.
Thiele DL; Lipsky PE
J Immunol; 1985 Feb; 134(2):786-93. PubMed ID: 3965574
[TBL] [Abstract][Full Text] [Related]
3. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets.
Thiele DL; Lipsky PE
J Immunol; 1986 Aug; 137(4):1399-406. PubMed ID: 3488348
[TBL] [Abstract][Full Text] [Related]
4. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
Thiele DL; Charley MR; Calomeni JA; Lipsky PE
J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
[TBL] [Abstract][Full Text] [Related]
5. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester.
Thiele DL; Kurosaka M; Lipsky PE
J Immunol; 1983 Nov; 131(5):2282-90. PubMed ID: 6605384
[TBL] [Abstract][Full Text] [Related]
6. Human peripheral blood gamma delta T cells are uniformly sensitive to destruction by the lysosomotropic agents leucine methyl ester and leucyl leucine methyl ester.
Pechhold K; Kabelitz D
Eur J Immunol; 1993 Feb; 23(2):562-5. PubMed ID: 8436187
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis is induced in cells with cytolytic potential by L-leucyl-L-leucine methyl ester.
Thiele DL; Lipsky PE
J Immunol; 1992 Jun; 148(12):3950-7. PubMed ID: 1602138
[TBL] [Abstract][Full Text] [Related]
8. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
Thiele DL; Bryde SE; Lipsky PE
J Immunol; 1988 Nov; 141(10):3377-82. PubMed ID: 3053897
[TBL] [Abstract][Full Text] [Related]
9. Depletion of NK cells with the lysosomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells.
Shau H; Golub SH
J Immunol; 1985 Feb; 134(2):1136-41. PubMed ID: 3871208
[TBL] [Abstract][Full Text] [Related]
10. Generalized toxicity of L-leucyl-leucine-methyl ester for lymphocyte functions.
Mowat AM; Leck PA
Immunology; 1990 Apr; 69(4):564-9. PubMed ID: 2335375
[TBL] [Abstract][Full Text] [Related]
11. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
12. Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.
Strassmann G; Bach FH; Zarling JM
J Immunol; 1983 Apr; 130(4):1556-60. PubMed ID: 6220056
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cellular function by products of lysosomal enzyme activity: elimination of human natural killer cells by a dipeptide methyl ester generated from L-leucine methyl ester by monocytes or polymorphonuclear leukocytes.
Thiele DL; Lipsky PE
Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2468-72. PubMed ID: 3857595
[TBL] [Abstract][Full Text] [Related]
14. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.
Lanier LL; Le AM; Cwirla S; Federspiel N; Phillips JH
Fed Proc; 1986 Nov; 45(12):2823-8. PubMed ID: 3095151
[TBL] [Abstract][Full Text] [Related]
15. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
Stanková J; Rola-Pleszczynski M
J Immunol; 1985 Dec; 135(6):3719-28. PubMed ID: 2415584
[TBL] [Abstract][Full Text] [Related]
16. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
Thiele DL; Calomeni JA; Lipsky PE
J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
[TBL] [Abstract][Full Text] [Related]
17. The effect of leucyl-leucine methyl ester on proliferation and Ig secretion of EBV-transformed human B lymphocytes.
Ohlin M; Danielsson L; Carlsson R; Borrebaeck CA
Immunology; 1989 Apr; 66(4):485-90. PubMed ID: 2541070
[TBL] [Abstract][Full Text] [Related]
18. Hydrocortisone suppresses the generation of nonspecific "anomalous" killers but not specific cytolytic T lymphocytes in human mixed lymphocyte-tumor cultures.
Muul LM; Gately MK
J Immunol; 1984 Mar; 132(3):1202-7. PubMed ID: 6198383
[TBL] [Abstract][Full Text] [Related]
19. The action of leucyl-leucine methyl ester on cytotoxic lymphocytes requires uptake by a novel dipeptide-specific facilitated transport system and dipeptidyl peptidase I-mediated conversion to membranolytic products.
Thiele DL; Lipsky PE
J Exp Med; 1990 Jul; 172(1):183-94. PubMed ID: 1972727
[TBL] [Abstract][Full Text] [Related]
20. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH
J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
